BRG’s Dr. Nick Chmielewski speaks with David Wildebrandt, a partner and managing director at BRG. They discuss key findings from BRG’s recent 2025 US Healthcare & Life Sciences Transactions Outlook report, including transactional evolution and industry disruptors.
Read the full article: Podcast: 2025 US Healthcare and Life Sciences Transactions Outlook //
Source: https://www.lexology.com/library/detail.aspx?g=ae6d2eb7-bf66-49fe-909b-2ad154fb5a50